Attenuation of COX-2 enzyme by modulating H2O2-mediated NF-κB signaling pathway by monoamine oxidase inhibitor (MAOI): a further study on the reprofiling of MAOI in acute inflammation

Inflammopharmacology. 2023 Jun;31(3):1305-1317. doi: 10.1007/s10787-023-01165-5. Epub 2023 Feb 24.

Abstract

Objective: This study aims to investigate the anti-inflammatory mechanism of monoamine oxidase inhibitor (MAOI) in carrageenan (CARR) induced inflammation models to reprofile their use. We also aimed to explore the role of monoamine oxidase (MAO)-mediated H2O2-NF-κB-COX-2 pathway in acute inflammation.

Methods: In vitro anti-inflammatory activity and hydrogen peroxide (H2O2) scavenging activity were performed according to the established procedure. Inflammation was induced using CARR in BALB/c mice at the foot paw and peritoneal cavity. Hourly measurement of paw swelling was performed. The level of nitric oxide (NO), myeloperoxidase (MPO), cyclooxygenase-2 (COX-2), prostaglandin E2 (PGE2) and nuclear factor κB (NF-κB) was determined using enzyme-linked immunosorbent assay (ELISA). Peritoneal fluid was collected to investigate total count, differential count of leukocytes, and capillary permeability.

Results: In vitro anti-inflammatory evaluations revealed the potential role of MAOI to inhibit heat-induced protein denaturation and human red cell membrane destabilization. H2O2 inhibition activity of MAOI also proved their powerful role as an H2O2 scavenger. Treatment with MAOI in CARR-induced mice significantly reduced paw edema, leukocyte extravasation, and total and differential leukocyte count. The result of ELISA showed MAOI effectively reduce the level of COX-2, PGE2 and NF-κB in inflamed tissue.

Conclusions: In short, this study demonstrates that inhibition of H2O2 by MAOI alleviates CARR-induced paw edema possibly by inhibiting the H2O2-mediated NF-κB-COX-2 pathway. The present investigation identifies MAOI might reprofile for the treatment of acute inflammation also, the MAO enzyme may use as a novel therapeutic target to design and develop new class of anti-inflammatory agents.

Keywords: COX-2; Carrageenan-induced paw edema; Inflammation; Monoamine oxidase; Monoamine oxidase inhibitor; NF-κB.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / therapeutic use
  • Carrageenan / pharmacology
  • Cyclooxygenase 2 / metabolism
  • Edema / metabolism
  • Humans
  • Hydrogen Peroxide* / metabolism
  • Inflammation / metabolism
  • Mice
  • Monoamine Oxidase / metabolism
  • Monoamine Oxidase / pharmacology
  • Monoamine Oxidase / therapeutic use
  • Monoamine Oxidase Inhibitors / adverse effects
  • NF-kappa B* / metabolism
  • Nitric Oxide / metabolism
  • Nitric Oxide Synthase Type II / metabolism
  • Signal Transduction

Substances

  • NF-kappa B
  • Cyclooxygenase 2
  • Hydrogen Peroxide
  • Monoamine Oxidase Inhibitors
  • Carrageenan
  • Anti-Inflammatory Agents
  • Monoamine Oxidase
  • Nitric Oxide
  • Nitric Oxide Synthase Type II